Mohini Health & Hygiene Limited (NSE:MHHL)
India · Delayed Price · Currency is INR 28.20
+1.30 (4.83%)
Nov 9, 2026, 3:15 PM IST
Mohini Health & Hygiene Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,445 | 1,678 | 1,996 | 1,920 | 1,363 |
Other Revenue | 0.67 | 0.04 | - | - | - |
| 1,445 | 1,678 | 1,996 | 1,920 | 1,363 | |
Revenue Growth | -13.86% | -15.95% | 3.96% | 40.83% | -1.10% |
Cost of Revenue | 1,085 | 1,260 | 1,590 | 1,493 | 976.23 |
Gross Profit | 360.3 | 417.91 | 406.17 | 427.3 | 387.24 |
Selling, General & Admin | 166.33 | 221.62 | 162.16 | 197.96 | 186.8 |
Other Operating Expenses | 215.13 | 66.76 | 102.36 | 99.25 | 79.45 |
Operating Expenses | 426.74 | 336.13 | 307.61 | 340.01 | 319.05 |
Operating Income | -66.44 | 81.79 | 98.57 | 87.29 | 68.19 |
Interest Expense | -32.32 | -26.92 | -35.93 | -34.9 | -34.3 |
Interest & Investment Income | 2.71 | 1.37 | 1.95 | 6.29 | 0.76 |
Earnings From Equity Investments | -4.36 | -0.81 | 0.1 | 0.04 | - |
Currency Exchange Gain (Loss) | 15.99 | 92.21 | 71.35 | 54.69 | 57.88 |
Other Non Operating Income (Expenses) | -4.42 | -3.71 | -4.93 | -6.57 | 6.66 |
EBT Excluding Unusual Items | -88.84 | 143.91 | 131.11 | 106.83 | 99.19 |
Gain (Loss) on Sale of Investments | 1.65 | 4.69 | 2.27 | -0.63 | - |
Gain (Loss) on Sale of Assets | 0.07 | - | - | - | 1.42 |
Other Unusual Items | -80.59 | -63.72 | - | - | -13.61 |
Pretax Income | -167.72 | 84.88 | 133.38 | 106.2 | 87.01 |
Income Tax Expense | -1.15 | 26.35 | 26.47 | 38.37 | 26.34 |
Earnings From Continuing Operations | -166.57 | 58.53 | 106.91 | 67.83 | 60.67 |
Minority Interest in Earnings | - | - | - | - | -3.25 |
Net Income | -166.57 | 58.53 | 106.91 | 67.83 | 57.42 |
Net Income to Common | -166.57 | 58.53 | 106.91 | 67.83 | 57.42 |
Net Income Growth | - | -45.26% | 57.61% | 18.13% | -2.97% |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 |
Shares Change | - | - | - | - | 0.00% |
EPS (Basic) | -9.13 | 3.21 | 5.86 | 3.72 | 3.15 |
EPS (Diluted) | -9.13 | 3.21 | 5.86 | 3.72 | 3.15 |
EPS Growth | - | -45.26% | 57.61% | 18.13% | -2.97% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -83.63 | 34.27 | 120.49 | 230.21 | -138.57 |
Free Cash Flow Per Share | -4.59 | 1.88 | 6.61 | 12.62 | -7.60 |
Dividend Per Share | - | - | 0.500 | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 24.93% | 24.91% | 20.35% | 22.25% | 28.40% |
Operating Margin | -4.60% | 4.88% | 4.94% | 4.55% | 5.00% |
Profit Margin | -11.53% | 3.49% | 5.36% | 3.53% | 4.21% |
Free Cash Flow Margin | -5.79% | 2.04% | 6.04% | 11.99% | -10.16% |
EBITDA | -21.16 | 129.53 | 141.66 | 130.08 | 114.09 |
EBITDA Margin | -1.46% | 7.72% | 7.10% | 6.78% | 8.37% |
D&A For EBITDA | 45.29 | 47.75 | 43.09 | 42.8 | 45.91 |
EBIT | -66.44 | 81.79 | 98.57 | 87.29 | 68.19 |
EBIT Margin | -4.60% | 4.88% | 4.94% | 4.55% | 5.00% |
Effective Tax Rate | - | 31.05% | 19.85% | 36.13% | 30.27% |
Revenue as Reported | 1,466 | 1,788 | 2,076 | 1,983 | 1,431 |
Advertising Expenses | 2.59 | 2.61 | 3.05 | 3.59 | 1.84 |